March 14, 2018
Rose
A recently released analysis report from the Deloitte Center for Government Insights that examines the US’s current and proposed software as a medical device (SaMD) regulatory landscape, and includes suggestions on how the FDA’s pre-certification pilot program and other initiatives could better serve this fast-moving industry.
from MobiHealthNews http://ift.tt/2pdyWQt
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment